thymopentin has been researched along with Hepatitis B, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, X; Gu, N; Guo, J; Lu, J; Ma, Y; Wang, J; Wu, H; Xiong, F | 1 |
| Shi, W; Tang, S; Zhang, W | 1 |
2 trial(s) available for thymopentin and Hepatitis B, Chronic
| Article | Year |
|---|---|
The effect of thymopentin add-on in hepatitis B e antigen positive chronic hepatitis B after virus suppression by peginterferon plus entecavir therapy.
Topics: Adult; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Thymopentin; Treatment Outcome | 2019 |
[Therapeutic effects of Lamivudine in combination with Thymopentin on chronic hepatitis B].
Topics: Adjuvants, Immunologic; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Thymopentin; Treatment Outcome | 2002 |